Working… Menu

Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01826487
Recruitment Status : Completed
First Posted : April 8, 2013
Last Update Posted : April 8, 2019
Information provided by (Responsible Party):
PTC Therapeutics